ADCs are currently at the forefront of cancer treatment, but persistent drug development challenges call for a new approach.

Drug developers' dreams of silencing RNA as a way to step in front of a range of diseases have not lived up to early-day hype ...

Weight-loss drugs aren’t just slimming waists; they create a $100 billion market opportunity. With plenty up for grabs, ...

Developing and deploying these machines costs millions of dollars, but a new report claims they could save the tech giant up to $10 billion a year by 2030. Amazon's use of robots in its ...

AbbVie's strategic move into the obesity market through a partnership with Gubra A/S shows potential but won't impact revenue ...

Gene therapy stocks are transforming healthcare with revolutionary treatments. Therefore, as this sector continues to evolve, ...

Amazon has stepped up its robotics development in recent years, and it could save the e-commerce giant as much as $10 billion annually, Morgan Stanley analysts wrote in a research note on Sunday.

Medication company Viatris (NASDAQ:VTRS) in Q4 CY2024, with sales falling 8.1% year on year to $3.53 billion. The company’s ...

Just two years ago, executives at Google parent company Alphabet were struggling to address a trend of lower advertising revenue at YouTube. Those days are now over. On Tuesday, Alphabet revealed ...

Stem cell research and regenerative medicine are growing markets in the life science sector, and the top stem cell companies ...

The company says the new locations are part of an approximately $10 billion investment over the next five years, including $2.2 billion this year.

Viatris Inc. (VTRS) recently reported a fourth quarter that fell short of Wall Street expectations, missing revenue and earnings targets. The ...